UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
| QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For The Quarterly Period Ended May 31, 2003
OR
| TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For The Transition Period From To
Commission File Number 1-5742
RITE AID CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware | 23-1614034 | |||||
| (State or other jurisdiction
of incorporation or organization) |
(I.R.S. Employer Identification No.) |
|||||
| 30 Hunter Lane, Camp Hill, Pennsylvania (Address of principal executive offices) |
17011 (Zip Code) |
|||||
Registrant's telephone number, including area code: (717) 761-2633
(Former name, former address and former fiscal year, if changed since last report) Not Applicable
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months, and (2) has been subject to such filing
requirements for the past 90 days. Yes
No
Indicate by check whether the registrant is an accelerated filer (as
defined in Rule 12b-2 of the Exchange Act). Yes
No
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.
The registrant had 515,408,556 shares of its $1.00 par value common stock outstanding as of June 27, 2003.
RITE AID CORPORATION
TABLE OF CONTENTS
| Page | ||||||||||
| Cautionary Statement Regarding Forward Looking Statements | 3 | |||||||||
| PART I FINANCIAL INFORMATION |
||||||||||
| ITEM 1. | Financial Statements: | |||||||||
| Condensed Consolidated Balance Sheets as of May 31, 2003 and March 1, 2003 | 4 | |||||||||
| Condensed Consolidated Statements of Operations for the Thirteen Week Periods Ended May 31, 2003 and June 1, 2002 | 5 | |||||||||
| Condensed Consolidated Statements of Cash Flows for the Thirteen Week Periods Ended May 31, 2003 and June 1, 2002 | 6 | |||||||||
| Notes to Condensed Consolidated Financial Statements | 7 | |||||||||
| ITEM 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations | 18 | ||||||||
| ITEM 3. | Quantitative and Qualitative Disclosures About Market Risk | 26 | ||||||||
| ITEM 4. | Controls and Procedures | 27 | ||||||||
| PART II OTHER INFORMATION |
||||||||||
| ITEM 1. | Legal Proceedings | 28 | ||||||||
| ITEM 2. | Changes in Securities and Use of Proceeds | 28 | ||||||||
| ITEM 3. | Defaults Upon Senior Securities | 28 | ||||||||
| ITEM 4. | Submission of Matters to a Vote of Security Holders | 28 | ||||||||
| ITEM 5. | Other Information | 28 | ||||||||
| ITEM 6. | Exhibits and Reports on Form 8-K | 29 | ||||||||
2
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This report includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are identified by terms and phrases such as "anticipate," "believe," "intend," "estimate," "expect," "continue," "should," "could," "may," "plan," "project," "predict," "will" and similar expressions and include references to assumptions and relate to our future prospects, developments and business strategies.
Factors that could cause actual results to differ materially from those expressed or implied in such forward-looking statements include, but are not limited to:
| • | our high level of indebtedness; |
| • | our ability to make interest and principal payments on our debt and satisfy the other covenants contained in our new senior secured credit facility and other debt agreements; |
| • | our ability to improve the operating performance of our existing stores in accordance with our management's long term strategy; |
| • | our ability to hire and retain pharmacists and other store personnel; |
| • | the outcomes of pending lawsuits and governmental investigations; |
| • | competitive pricing pressures and continued consolidation of the drugstore industry; and |
| • | the efforts of third party payors to reduce prescription drug costs, changes in state or federal legislation or regulations, the success of planned advertising and merchandising strategies, general economic conditions and inflation, interest rate movements, access to capital, and our relationships with our suppliers. |
We undertake no obligation to revise the forward-looking statements included in this report to reflect any future events or circumstances. Our actual results, performance or achievements could differ materially from the results expressed in, or implied by, these forward-looking statements. Factors that could cause or contribute to such differences are discussed in the section entitled "Management's Discussion and Analysis of Financial Condition and Results of Operations—Overview and Factors Affecting Our Future Prospects" included in our Annual Report on Form 10-K for the fiscal year ended March 1, 2003 ("the Fiscal 2003 10-K"), which we filed with the Securities and Exchange Commission ("SEC") on May 2, 2003 and is available on the SEC's website at www.sec.gov.
3
PART I. FINANCIAL INFORMATION
ITEM 1. Financial Statements
RITE AID CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per share
amounts)
(unaudited)
| May 31, 2003 | March 1, 2003 | |||||||||
| ASSETS | ||||||||||
| CURRENT ASSETS: | ||||||||||
| Cash and cash equivalents | $ | 342,742 | $ | 365,321 | ||||||
| Accounts receivable, net | 628,348 | 575,518 | ||||||||
| Inventories, net | 2,226,611 | 2,195,030 | ||||||||
| Prepaid expenses and other current assets | 98,851 | 108,018 | ||||||||
| Total current assets | 3,296,552 | 3,243,887 | ||||||||
| PROPERTY, PLANT AND EQUIPMENT, NET | 1,932,726 | 1,868,579 | ||||||||
| GOODWILL | 684,535 | 684,535 | ||||||||
| OTHER INTANGIBLES, NET | 195,190 | 199,768 | ||||||||
| OTHER ASSETS | 130,097 | 136,746 | ||||||||
| Total assets | $ | 6,239,100 | $ | 6,133,515 | ||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||||
| CURRENT LIABILITIES: | ||||||||||
| Short-term debt and current maturities of long-term debt and lease financing obligations | $ | 70,911 | $ | 103,715 | ||||||
| Accounts payable | 837,445 | 755,284 | ||||||||
| Accrued salaries, wages and other current liabilities | 684,434 | 707,999 | ||||||||
| Total current liabilities | 1,592,790 | 1,566,998 | ||||||||
| CONVERTIBLE NOTES | 244,875 | 244,500 | ||||||||
| LONG-TERM DEBT, LESS CURRENT MATURITIES | 3,465,797 | 3,345,365 | ||||||||
| LEASE FINANCING OBLIGATIONS, LESS CURRENT MATURITIES | 167,121 | 169,048 | ||||||||
| OTHER NONCURRENT LIABILITIES | 889,464 | 900,270 | ||||||||
| Total liabilities | 6,360,047 | 6,226,181 | ||||||||
| COMMITMENTS AND CONTINGENCIES | — | — | ||||||||
| REDEEMABLE PREFERRED STOCK | 19,689 | 19,663 | ||||||||
| STOCKHOLDERS' DEFICIT: | ||||||||||
| Preferred stock, par value $1 per share, liquidation value $100 per share | 393,705 | 393,705 | ||||||||
| Common stock, par value $1 per share | 515,372 | 515,115 | ||||||||
| Additional paid-in capital | 3,135,246 | 3,119,619 | ||||||||